Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Alnylam Pharmace. buy Royal Bank of Canada

Alnylam Pharmace.
Start price
€174.00
25.07.23 / 50%
Target price
€244.30
25.07.24
Performance (%)
25.86%
End price
€219.00
26.07.24
Summary
This prediction ended on 26.07.24 with a price of €219.00. The BUY prediction by Royal_Bank_of_Canada finished with a performance of 25.86%. Royal_Bank_of_Canada has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Royal_Bank_of_Canada has 50% into this prediction

Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.

Performance without dividends (%)
Name 1w 1m 1y
Alnylam Pharmace. 6.196% 6.196% 42.166%
iShares Core DAX® 1.887% 1.967% 17.000%
iShares Nasdaq 100 2.316% -1.227% 22.986%
iShares Nikkei 225® 1.134% 0.390% 9.520%
iShares S&P 500 1.821% 0.790% 22.957%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Alnylam Pharmace. diskutieren
Prediction Buy
Perf. (%) 25.86%
Target price 244.296
Change
Ends at 25.07.24

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target lowered by analysts at Royal Bank of Canada from $275.00 to $270.00. They now have an "outperform" rating on the stock.
Ratings data for ALNY provided by MarketBeat

Royal Bank of Canada 
0
Report Share
25.07.23
In the thread Trading Alnylam Pharmace.
Prediction Buy
Perf. (%) 25.86%
Target price 244.296
Change
Ends at 25.07.24

Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

Royal Bank of Canada 
0
Report Share
26.07.24

Current prediction by Royal_Bank_of_Canada for Alnylam Pharmace.

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€167.00
06.10.23
€256.26
06.10.24
48.80%
14:04

Royal Bank of Canada 
06.10.23 50%

Stopped prediction by Royal_Bank_of_Canada for Alnylam Pharmace.

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€228.50
04.09.24
€270.99
04.09.25
8.75%
14:04

Royal Bank of Canada 
04.09.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€249.10
02.08.24
€274.83
02.08.25
-0.24%
14:04

Royal Bank of Canada 
02.08.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€221.10
25.06.24
€233.58
25.06.25
12.39%
14:04

Royal Bank of Canada 
25.06.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€137.40
20.02.24
€217.07
20.02.25
80.86%
14:04

Royal Bank of Canada 
20.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€152.00
14.02.24
€219.11
14.02.25
63.49%
14:04

Royal Bank of Canada 
14.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€155.80
03.11.23
€214.15
03.11.24
59.50%
14:04

Royal Bank of Canada 
03.11.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€195.00
12.09.23
€251.80
12.09.24
20.97%
13.09.24

Royal Bank of Canada 
12.09.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€177.00
28.08.23
€249.78
28.08.24
46.16%
29.08.24

Royal Bank of Canada 
28.08.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€171.20
18.08.23
€248.29
18.08.24
40.77%
19.08.24

Royal Bank of Canada 
18.08.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€168.60
04.08.23
€244.57
04.08.24
44.72%
05.08.24

Royal Bank of Canada 
04.08.23 50%